Corrigendum to “Quantum dot labeling using positive charged peptides in human hematopoetic and mesenchymal stem cells” [Biomaterials 32 (2011) 5195–5205] (Biomaterials (2011) 32(22) (5195–5205), (S0142961211003863), (10.1016/j.biomaterials.2011.04.004));Quantum dot labeling using positive charged peptides in human hematopoetic and mesenchymal stem cells

Biomaterials

Volumn 32, Issue 22, 2011, Pages 5195-5205

  Ranjbarvaziri, Sarah ^a,b   Kiani, Sahar ^a   Akhlaghi, Aliasghar ^a   Vosough, Ahmad ^a   Baharvand, Hossein ^a,b   Aghdami, Nasser ^a  

^a ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^b UNIVERSITY OF SCIENCE AND CULTURE   (Iran)

Author keywords

Cell labeling; Cytotoxicity; Entrance efficiency; Positive charged peptides; Quantum dots; Stability

Indexed keywords

CELL CULTURE; CONVERGENCE OF NUMERICAL METHODS; CYTOTOXICITY; FLOWCHARTING; GRAPHENE QUANTUM DOTS; NANOCRYSTALS; NANOPARTICLES; PARTICLE SIZE; PEPTIDES; STEM CELLS;

CELL LABELING; CELLULAR DELIVERY; COLONY FORMING ASSAYS; DELETERIOUS EFFECTS; FLUORESCENT PROBES; MESENCHYMAL STEM CELL; POSITIVELY CHARGED PEPTIDES; QUANTUM DOT LABELING;

SEMICONDUCTOR QUANTUM DOTS;

CD133 ANTIGEN; CD14 ANTIGEN; CD34 ANTIGEN; LACTATE DEHYDROGENASE; NANOPARTICLE; PEPTIDE DERIVATIVE; QUANTUM DOT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL LABELING; CELL LINEAGE; CELL TRANSPLANTATION; CELL TYPE; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; ENZYME RELEASE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERNALIZATION; MALE; MESENCHYMAL STEM CELL; NICK END LABELING; NONHUMAN; PARTICLE SIZE; PINOCYTOSIS; PRIORITY JOURNAL; RAT; TECHNIQUE;

ANIMALIA;

EID: 79956090695     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2021.120691     Document Type: Erratum

References (46)

1. Beeres S.L., Bengel F.M., Bartunek J., Atsma D.E., Hill J.M., Vanderheyden M., et al. Role of imaging in cardiac stem cell therapy. J Am Coll Cardiol 2007, 49(11):1137-1148.
2. Stodilka R.Z., Blackwood K.J., Kong H., Prato F.S. A method for quantitative cell tracking using SPECT for the evaluation of myocardial stem cell therapy. Nucl Med Commun 2006, 27(10):807-813.
3. Wilhelm C., Gazeau F. Universal cell labelling with anionic magnetic nanoparticles. Biomaterials 2008, 29(22):3161-3174.
4. Templin C., Kotlarz D., Marquart F., Faulhaber J., Brendecke V., Schaefer A., et al. Transcoronary delivery of bone marrow cells to the infarcted murine myocardium: feasibility, cellular kinetics, and improvement in cardiac function. Basic Res Cardiol 2006, 101(4):301-310.
5. Stadtfeld M., Varas F., Graf T. Fluorescent protein-cell labeling and its application in time-lapse analysis of hematopoietic differentiation. Methods Mol Med 2005, 105:395-412.
6. Gao X., Chan W.C., Nie S. Quantum-dot nanocrystals for ultrasensitive biological labeling and multicolor optical encoding. J Biomed Opt 2002, 7(4):532-537.
7. Ballou B., Lagerholm B.C., Ernst L.A., Bruchez M.P., Waggoner A.S. Noninvasive imaging of quantum dots in mice. Bioconjug Chem 2004, 15(1):79-86.
8. Michalet X., Pinaud F.F., Bentolila L.A., Tsay J.M., Doose S., Li J.J., et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005, 307(5709):538-544.
9. Medintz I.L., Uyeda H.T., Goldman E.R., Mattoussi H. Quantum dot bioconjugates for imaging, labelling and sensing. Nat Mater 2005, 4(6):435-446.
10. Rosen A.B., Kelly D.J., Schuldt A.J., Lu J., Potapova I.A., Doronin S.V., et al. Finding fluorescent needles in the cardiac haystack: tracking human mesenchymal stem cells labeled with quantum dots for quantitative in vivo three-dimensional fluorescence analysis. Stem Cells 2007, 25(8):2128-2138.
11. Slotkin J.R., Chakrabarti L., Dai H.N., Carney R.S., Hirata T., Bregman B.S., et al. In vivo quantum dot labeling of mammalian stem and progenitor cells. Dev Dyn 2007, 236(12):3393-3401.
12. Jaiswal J.K., Mattoussi H., Mauro J.M., Simon S.M. Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nat Biotechnol 2003, 21(1):47-51.
13. Muller-Borer B.J., Collins M.C., Gunst P.R., Cascio W.E., Kypson A.P. Quantum dot labeling of mesenchymal stem cells. J Nanobiotechnology 2007, 5:9.
14. Lin S., Xie X., Patel M.R., Yang Y.H., Li Z., Cao F., et al. Quantum dot imaging for embryonic stem cells. BMC Biotechnol 2007, 7:67.
15. Voura E.B., Jaiswal J.K., Mattoussi H., Simon S.M. Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy. Nat Med 2004, 10(9):993-998.
16. Pi Q.M., Zhang W.J., Zhou G.D., Liu W., Cao Y. Degradation or excretion of quantum dots in mouse embryonic stem cells. BMC Biotechnol 2010, 10:36.
17. Dubertret B., Skourides P., Norris D.J., Noireaux V., Brivanlou A.H., Libchaber A. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 2002, 298(5599):1759-1762.
18. Chen F., Gerion D. Fluorescent Cdse/Zns nanocrystal-peptide conjugates for long-term, nontoxic imaging and nuclear targeting in living cells. Nano Lett 2004, 4(10):1827-1832.
19. Ruan G., Agrawal A., Marcus A.I., Nie S. Imaging and tracking of tat peptide-conjugated quantum dots in living cells: new insights into nanoparticle uptake, intracellular transport, and vesicle shedding. J Am Chem Soc 2007, 129(47):14759-14766.
20. Delehanty J.B., Mattoussi H., Medintz I.L. Delivering quantum dots into cells: strategies, progress and remaining issues. Anal Bioanal Chem 2009, 393(4):1091-1105.
21. Gao X., Cui Y., Levenson R.M., Chung L.W., Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004, 22(8):969-976.
22. Hardman R. A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ Health Perspect 2006, 114(2):165-172.
23. Sun Y., Liu Y.S., Vernier P.T., Liang C.H., Chong S.Y., Marcu L., et al. Photostability and pH sensitivity of CdSe/ZnSe/ZnS quantum dots in living cells. Nanotechnology 2006, 17(17):4469-4476.
24. Garon E.B., Marcu L., Luong Q., Tcherniantchouk O., Crooks G.M., Koeffler H.P. Quantum dot labeling and tracking of human leukemic, bone marrow and cord blood cells. Leuk Res 2007, 31(5):643-651.
25. Hoshino A., Hanaki K., Suzuki K., Yamamoto K. Applications of T-lymphoma labeled with fluorescent quantum dots to cell tracing markers in mouse body. Biochem Biophys Res Commun 2004, 314(1):46-53.
26. Kekarainen T., Mannelin S., Laine J., Jaatinen T. Optimization of immunomagnetic separation for cord blood-derived hematopoietic stem cells. BMC Cell Biol 2006, 7:30.
27. Coulombel L., Eaves A.C., Eaves C.J. Enzymatic treatment of long-term human marrow cultures reveals the preferential location of primitive hemopoietic progenitors in the adherent layer. Blood 1983, 62(2):291-297.
28. Boutonnat J., Barbier M., Rousselle C., Muirhead K.A., Mousseau M., Seigneurin D., et al. Usefulness of PKHs for studying cell proliferation. C R Acad Sci 1998, 321(11):901-907.
29. Hatami M., Mehrjardi N.Z., Kiani S., Hemmesi K., Azizi H., Shahverdi A., et al. Human embryonic stem cell-derived neural precursor transplants in collagen scaffolds promote recovery in injured rat spinal cord. Cytotherapy 2009, 11(5):618-630.
30. Wadia J.S., Stan R.V., Dowdy S.F. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 2004, 10(3):310-315.
31. Snyder E.L., Dowdy S.F. Cell penetrating peptides in drug delivery. Pharm Res 2004, 21(3):389-393.
32. Chithrani B.D., Chan W.C. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett 2007, 7(6):1542-1550.
33. Chithrani B.D., Ghazani A.A., Chan W.C. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 2006, 6(4):662-668.
34. Yukawa H., Mizufune S., Mamori C., Kagami Y., Oishi K., Kaji N., et al. Quantum dots for labeling adipose tissue-derived stem cells. Cell Transplant 2009, 18(5):591-599.
35. Lin X., Li Y., Gu N. Nanoparticles size effect on its translocation across a lipid bilayer a molecular dynamics simulation. J Comput Theor Nanosci 2010, 7(1):269-276.
36. Panyam J., Labhasetwar V. Dynamics of endocytosis and exocytosis of poly(d, l-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells. Pharm Res 2003 Feb, 20(2):212-220.
37. Jiang X., Rocker C., Hafner M., Brandholt S., Dorlich R.M., Nienhaus G.U. Endo- and exocytosis of zwitterionic quantum dot nanoparticles by live HeLa cells. ACS Nano 2010, 4(11):6787-6797.
38. Lewin M., Carlesso N., Tung C.H., Tang X.W., Cory D., Scadden D.T., et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 2000, 18(4):410-414.
39. Seleverstov O., Zabirnyk O., Zscharnack M., Bulavina L., Nowicki M., Heinrich J.M., et al. Quantum dots for human mesenchymal stem cells labeling. A size-dependent autophagy activation. Nano Lett 2006, 6(12):2826-2832.
40. Derfus A.M., Chan W.C.W., Bhatia S.N. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 2004, 4(1):11-18.
41. Lewinski N., Colvin V., Drezek R. Cytotoxicity of nanoparticles. Small 2008, 4(1):26-49.
42. Shah B.S., Clark P.A., Moioli E.K., Stroscio M.A., Mao J.J. Labeling of mesenchymal stem cells by bioconjugated quantum dots. Nano Lett 2007, 7(10):3071-3079.
43. Chen B., Liu Q., Zhang Y., Xu L., Fang X. Transmembrane delivery of the cell-penetrating peptide conjugated semiconductor quantum dots. Langmuir 2008, 24(20):11866-11871.
44. Baksh D., Song L., Tuan R.S. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cellular Molecular Medicine 2004, 8(3):301-316.
45. Estrada C.R., Salanga M., Bielenberg D.R., Harrell W.B., Zurakowski D., Zhu X., et al. Behavioral profiling of human transitional cell carcinoma ex vivo. Cancer Res 2006, 66(6):3078-3086. 15.
46. Dupont K.M., Sharma K., Stevens H.Y., Boerckel J.D., Garcia A.J., Guldberg R.E. Human stem cell delivery for treatment of large segmental bone defects. Proc Natl Acad Sci U S A 2010, 107(8):3305-3310.